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Garett and Masuda (p. 818) review the accumulating evidence for
endometrial stem cells, identify their likely sources and discuss their
potential roles in endometrial proliferative disorders. Stem cells
reside within ﬁxed tissue compartments (niches). These specialized
highly regulated microenvironments (surrounding cells, extracellular
matrices and factors/signals) control the normal rate of stem cell
proliferation, survival and fate. Alterations to this intricate control
could result in stem cell transformation. Evidence that stem cell
transformation could be the underlying cause in reproductive cancer
is presented and the exciting potential for future stem cell studies to
lead to new reproductive cancer therapies is discussed.
Stem cells from the human placenta, cord blood, amniotic ﬂuid and
menstrual blood (among other reproductive tissues) are a rich, noninvasive and ethically acceptable source of stem cells. These stem
cells can be used for regenerative medicine and are potentially amenable to reprogramming for use in various patient-speciﬁc cell therapies.
Many of these reproductive stem cells express known pluripotency
factors such as Octamer 4 (OCT4) and SRY (sex determining
region Y)-box 2. David Kristensen et al. (p. 835) demonstrate for
the ﬁrst time that OCT4 and its downstream factors are expressed
in human somatic epithelial cells from the urogenital tract and that
these cells can form spheres, a general characteristic of stem cell
behaviour. Meyer et al. (p. 846) show through DNA microarray
analysis that maGSCs and ESCs exhibit comparable transcriptomes,
including genes associated with pluripotency and that both cell types
spontaneously differentiate in a similar manner. Masip et al. (p. 856)
summarizes the cellular reprogramming ﬁeld and compares the procedures and efﬁciency of induced pluripotent stem cell (iPSC) generated
from various somatic cell types including those from reproductive
tissues. The current limitations of induced pluripotency are presented
and innovative strategies for iPSC generation such as small molecule
iPSC generation and non-integrated transgenic methods are discussed.
The hot research topic of direct transdifferentiation, which has considerable implications for cellular therapy, is also reviewed.
Despite decades of research, the biological role(s) of fetal microchimerism (FMC) remain obscure. Several recent studies have demonstrated that fetal stem cells are the likely source of these cells.
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Welcome to this thematic MHR issue on ‘Stem cell roles in reproduction: what is the basic science?’ The aim of this Special Issue is to
emphasize the emerging role(s) of stem cells in reproduction. We
are pleased to showcase ﬁve original research articles and three
New Research Horizon reviews, which integrate the exciting ﬁelds
of reproduction and stem cells. These papers will contribute new
insights into the functions of reproductive stem cells, challenge
dogmas and create new paradigms for reproductive biology research.
Virtually all post-natal organs, including those of the reproductive
system, contain small populations of stem cells that have the capacity
for growth, homeostasis and repair of many tissues after damage or
ageing. MicroRNAs have emerging roles in the control of virtually all biological processes, including the biology of stem cells. In reproduction,
germ-line stem cells (GSCs) serve as a source for gamete production
and also give rise to cells with embryonic stem cell (ESC) properties
when cultured under specialized conditions. In this issue, Zovoilis et al.
(p. 793) demonstrate that multipotent adult GSCs (maGSCs) derived
from adult mouse testis express germ cell markers characteristic for primordial germ cells and display a speciﬁc microRNA expression proﬁle
that shows a connection to their germ cell origin but also inﬂuences
their differentiation potential when compared with the microRNA
expression pattern of differentiating ESCs. Jung et al. (p. 804) presents
an original research article on distinct microRNA signatures in various
testes-derived male GSCs and suggests that differential expression
could serve as a screening tool to distinguish between GSCs and
maGSCs to avoid teratoma formation after clinical transplantation for
male infertility. As a way to conﬁrm diagnosis in azoospermic patients,
Medrano et al. (p. 811) compare the expression proﬁles of germ cell
markers c-KIT, stage-speciﬁc embryonic antigen-1 and VASA and
found different expression proﬁles depending on the azoospermic aetiology suggesting that such a screen could be a complementary tool to discriminate between mosaic and non-mosaic Sertoli-cell only patients.
Following menstruation endometrial regeneration is thought to
involve small populations of resident multipotent stem cells, or stem
cells originating from the bone marrow. The discovery of these
uterine stem cells supports a new theory for the cause of endometriosis, which may arise after ectopic stem cell transdifferentiation.
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Once fetal stem cells enter the maternal circulation early in pregnancy,
they have the potential for a beneﬁcial contribution to tissue repair, or
a malevolent contribution to disease, depending on the tissue (niche)
they eventually reside in. Lee et al. (p. 869) provide an extensive
review on fetal stem cell microchimerism, which examines the
methods used for FMC detection, the origin prevalence and ‘stemness’ of stem cells implicated in FMC, the possible contribution of
FMC to various illnesses such as autoimmune diseases and cancer,
and ﬁnally the potential utility of fetal stem cells for therapies.
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Overall, these articles sum up the current focal points of stem
cell research in reproductive medicine and encapsulate the
essence of MHR, which seeks to publish and disseminate fundamental knowledge on the molecular aspects of human reproduction. Unravelling the functions of various stem cells in
reproduction will increase our fundamental knowledge of the
normal process of reproduction, provide insight into their role in
disease and help develop strategies to harness their therapeutic
potential. Enjoy the issue.
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